Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-992-3 | CAS number: 420-04-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1987
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 987
- Report date:
- 1987
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EPA OPP 84-2
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- Cyanamide
- EC Number:
- 206-992-3
- EC Name:
- Cyanamide
- Cas Number:
- 420-04-2
- Molecular formula:
- CH2N2
- IUPAC Name:
- cyanamide
- Test material form:
- other: aqueous solution
- Details on test material:
- - Test substance: Hydrogen cyanamide
- Purity: 50 % w/w (equivalent to 53 % w/v)
- Appearance: Clear, pale yellow liquid
- Batch: 02/10/86
Constituent 1
Method
- Target gene:
- Not applicable (no target gene)
Species / strain
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix prepared from Aroclor 1254 induced male Sprague-Dawley rat liver
- Test concentrations with justification for top dose:
- CHO cells were exposed to the test substance for 20 hours at concentrations of 42.4, 56.5, 141, 283 and 424 µg/mL in the non-activation assay and for 2 hours at 438, 875, 1310 and 1750 µg/mL (20 hours preparation interval) and 321 and 428 µg/mL (10 hours preparation interval) in the presence of metabolic activation.
+S9: 438- 1310 µg/mL - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Culture medium
Controlsopen allclose all
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- 80 ng/mL for the non-activation set
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- 17.5 and 50 µg/mL requiring activation
- Details on test system and experimental conditions:
- Cells were harvested at 10 (with S9 mix) and 20 hours (with and without S9 mix), respectively after treatment had commenced. For the final 2.5 hours prior to harvest, cultures were exposed to colcemide. These test conditions had been selected on the basis of a preliminary range-finding test.
Following harvest, cells were fixed on slides, stained and examined for chromosomal aberrations. 100 cells from each duplicate culture were analysed, except at 283 µg/mL without and 1.310 µg/mL with metabolic activation at the 20 hour preparation interval where only 50 cells were investigated. - Statistics:
- Fishe´s Exact Test (p<0.01)
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- without
- Genotoxicity:
- positive
- Remarks:
- 4 concentrations were analysed beginning at 42.4 up to 283 µg/mL. A significant increase was obtained at 141 and 283 µg/mL and a dose-response was established.
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- A complete toxicity at 424 and 565 µg/mL and a reduction in observable mitotic cells was obtained at 283 µg/mL.
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with
- Genotoxicity:
- positive
- Remarks:
- At 20 h preparation interval (438, 875 and 1.310 µg/ml) a significant dose-dependent increase in aberrant cells was obtained beginning at the lowest concentration. In the 10 hour preparation interval a slight but not significant abberations increase.
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- complete toxicity was obtained at 1.750 µg/mL and few mitotic cells were discernible at 1.310 µg/mL.
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- - In the preliminary concentration finding test, CHO cells were exposed to culture medium and to various concentrations of hydrogen cyanamide ranging from 17.7 µg/mL to 5.300 µg/mL in the absence and in the presence of S9 mix. Without metabolic activation a significant cell cycle delay was obtained beginning 53.0 and 177 µg/mL. Complete toxicity was obtained above concentrations of 530.0 µg/mL without S9 mix. Therefore, a 20 hour preparation interval was selected for testing a dose range of 28.2 µg/mL to 565 µg/mL without metabolic activation.
In the presence of metabolic activation complete toxicity was observed at 1750 µg/mL. A cell cycle delay was obtained at 530 µg/mL. Therefore, two harvest times were selected for the aberration assay with a dose range of 437 to 1750 µg/mL at the 20 hour preparation interval and a dose range of 107 µg/mL to 428 µg/mL at 10 hour preparation interval.
Any other information on results incl. tables
Table 1: Chromosome aberrations in Chinese hamster ovary (CHO) cells:
Test groups/Concentrations | Cells scored | % Cells with aberrations without gaps |
Fixation interval 20 h after treatment without S9 mix |
|
|
|
|
|
Negative and Solvent control | 200 | 2.0 |
Mitomycin C 80 ng/ml | 25 | 28.0* |
42.4 | 200 | 1.0 |
56.5 | 200 | 1.5 |
141.0 | 200 | 33.5* |
283.0 | 50** | 96.0* |
424 | - | - |
|
|
|
Fixation interval 20 h after treatment with S9 mix |
|
|
|
|
|
Negative and Solvent control | 200 | 1.0 |
Cyclophosphamide 17.5 µg/ml | 25 | 36.0* |
438.0 | 200 | 6.0* |
875.0 | 200 | 42.0* |
1310.0 | 50** | 94.0* |
1750.0 | - | - |
|
|
|
Fixation interval 10 h after treatment with S9 mix |
|
|
|
|
|
Negative and Solvent control | 200 | 1.5 |
Cyclophosphamide 17.5 µg/ml | 25 | 16.0* |
321.0 | 200 | 1.5 |
428.0 | 200 | 5.0 |
* statistically significant by Fisher's Exact Test (p<0.01)
** highly toxic effects
- no scorable metaphases
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of the assay described in this report, Hydrogen cyanamide induced an increase in structural chromosome aberrations in CHO cells and should be considered as clastogenic in this test system.
It is concluded, that cyanamide has a clastogenic potential in vitro. However, the clasogenic effects observed in vitro could not be detected in vivo. Therefore, cyanamide is considered to be not clastogenic in vivo. - Executive summary:
Hydrogen cyanamide was assessed for its potential to induce structural chromosome aberrations in Chinese hamster ovary (CHO) cells in vitro. Hydrogen cyanamide was tested in the presence and absence of metabolic activation (S9 mix prepared from Aroclor 1254 induced male Sprague-Dawley rat liver). The test article was dissolved in culture medium. Duplicate cultures of CHO cells were exposed to the test substance for 20 hours at concentrations of 42.4, 56.5, 141, 283 and 424 µg/mL in the non-activation assay and for 2 hours at 438, 875, 1310 and 1750 µg/mL(20 hours preparation interval) and 321 and 428 µg/mL(10 hours preparation interval) in the presence of metabolic activation. Cells were harvested at 10 (with S9 mix) and 20 hours (with and without S9 mix), respectively after treatment had commenced. For the final 2.5 hours prior to harvest, cultures were exposed to colcemide. These test conditions had been selected on the basis of a preliminary range-finding test which was also described in the original report. Following harvest, cells were fixed on slides, stained and examined for chromosomal aberrations. 100 cells from each duplicate culture were analysed, except at 283 µg/mL without and 1.310 µg/mL with metabolic activation at the 20 hour preparation interval where only 50 cells were investigated. Mitomycin C (80 ng/mL for the non-activation set) and cyclophosphamide (17.5 and 50 µg/ml, respectively requiring activation) served as positive control substances. An untreated negative control (culture medium) was also included in the testing.
In the main experiment without metabolic activation there was complete toxicity at 424 and 565 µg/mL and a reduction in observable mitotic cells was obtained at 283 µg/ml. 4 concentrations were analysed beginning at 42.4 up to 283 µg/ml. A significant increase was obtained at 141 and 283 µg/mL and a dose-response was established. With metabolic activation complete toxicity was obtained at 1.750 µg/mL and few mitotic cells were discernible at 1.310 µg/ml. Three concentrations (438, 875 and 1.310 µg/ml) were evaluated at the 20 hour preparation interval. In this experiment a significant dose-dependent increase in aberrant cells was obtained beginning at the lowest concentration. In the 10 hour preparation interval 2 concentrations 321 and 428 µg/mL were evaluated with no observable toxicity at the highest concentration. In this experiment a slight but not significant increase in cells with chromosomal aberrations was obtained at the highest investigated concentration.
Under the conditions of the assay described in this report, Hydrogen cyanamide induced an increase in structural chromosome aberrations in CHO cells and should be considered as clastogenic in this test system.
It is concluded, that cyanamide has a clastogenic potential in vitro. However, the clastogenic effects observed in vitro could not be detected in vivo. Therefore, cyanamide is considered to be not clastogenic in vivo.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.